CN101810737A - Chinese medicinal preparation for treating pelvic inflammation - Google Patents
Chinese medicinal preparation for treating pelvic inflammation Download PDFInfo
- Publication number
- CN101810737A CN101810737A CN200910211286A CN200910211286A CN101810737A CN 101810737 A CN101810737 A CN 101810737A CN 200910211286 A CN200910211286 A CN 200910211286A CN 200910211286 A CN200910211286 A CN 200910211286A CN 101810737 A CN101810737 A CN 101810737A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicinal
- medicinal preparation
- radix
- pelvic inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 10
- 241000218176 Corydalis Species 0.000 claims abstract description 4
- 241001071795 Gentiana Species 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 235000021419 vinegar Nutrition 0.000 claims abstract description 4
- 239000000052 vinegar Substances 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 241000501098 Sargentodoxa Species 0.000 claims description 3
- 241000405217 Viola <butterfly> Species 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 3
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 230000001684 chronic effect Effects 0.000 abstract description 5
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 230000001154 acute effect Effects 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 230000035619 diuresis Effects 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 239000004863 Frankincense Substances 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000006754 Taraxacum officinale Nutrition 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 241000555712 Forsythia Species 0.000 description 2
- 241000157835 Gardenia Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001741 anti-phlogistic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal preparation for treating pelvic inflammation. The Chinese medicinal preparation comprises the following selected raw material medicaments in part by weight: 50 parts of taraxacum officinale root, 20 parts of weeping forsythia, 12 parts of sevenlobed yam rhizome, 12 parts of honeysuckle flower, 20 parts of heartleaf houttuynia herb, 15 parts of sargentgloryvine stem, 25 parts of suberect spatholobus stem, 10 parts of processed frankincense, 10 parts of processed myrrh, 10 parts of Szechwan chinaberry fruit, 12 parts of rhizoma corydalis, 12 parts of gentian, 10 parts of fried gardenia, 10 parts of plantain seed, 12 parts of Chinese angelica, 10 parts of vinegar bupleurum, 10 parts of oriental waterplantain rhizome, 10 parts of raw liquoric root, 10 parts of violet and 10 parts of cortex moutan. The preparation comprises all formulations which is cilinically acceptable and suitable for oral administration. When the selected raw material medicaments are used together, the Chinese medicinal preparation has the effects of activating blood and dissolving stasis, clearing heat and promoting diuresis, and sterilizing and diminishing inflammation. The Chinese medicinal preparation has good curative effect on acute and chronic pelvic inflammation. The Chinese medicinal preparation has the advantages of exact curative effect, low treatment cost, no toxic or side effects, and no relapse after curing.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of pelvic inflammatory disease.
Background technology
Female internal genital organs reaches connective tissue on every side, when pelvic peritoneum is inflamed, is called pelvic inflammatory disease (pelic inflammatory disease).Pelvic inflammatory disease is the commonly encountered diseases of gynecological.Inflammation can be confined to a position, also can fall ill simultaneously at several positions.Can be divided into acute and chronic two kinds by its pathogenic process, clinical manifestation.
The cause of disease of pelvic inflammatory disease is nothing more than underlying cause: 1, infect puerperal or post-abortion; 2, gynecilogical operation infects; 3, menstrual phase is not noted health; 4, the inflammation direct extension of adjacent organs; 5, acute attack of chronic pelvic inflammatory disease etc.The pathogen that causes pelvic inflammatory disease is: staphylococcus, escherichia coli, anaerobe, the pathogen that spreads through sex intercourse.
Treatment by Chinese herbs is the rule of treatment with clearing away heat-damp and promoting diuresis, blood circulation promoting and blood stasis dispelling.Chinese Traditional Medicines have: suppository of wild chrysanthemum flower, JINJI JIAONANG, " Fubao " instant granular preparation, dysmenorrhes ball, wet through ball etc.
China Patent No. is that 2007101810928 patent of invention discloses " a kind of Chinese medicine preparation for the treatment of gynecology pelvic inflammatory disease ".Be used as medicine with Chinese medicines such as Herba Melastomatis dodecandri, Radix Zanthoxyli, Radix Angelicae Sinensis, Lignum Cudraniae tricuspidatae, Herba Fici Simplicissimae, make Oral preparation and be used for the treatment of pelvic cavity.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine preparation, good efficacy is all arranged at acute and chronic pelvic inflammatory disease with blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis, bactericidal antiphlogistic effect.
Raw medicinal material and composition by weight thereof that the present invention chooses are respectively: 50 parts of Herba Taraxaci, 20 parts of Fructus Forsythiaes, finish slack 12 parts, 12 parts of Flos Lonicerae, 20 parts of Herba Houttuyniae, 15 parts of Caulis Sargentodoxaes, 25 parts of Caulis Spatholobis, go into 10 parts of fragrant systems, 10 parts of Myrrha systems, 10 parts of Fructus Toosendans, 12 parts of Rhizoma Corydalis, 12 parts of Radix Gentianaes, fry 10 parts of mountain Gardenia, 10 parts of Semen Plantaginiss, 12 parts of Radix Angelicae Sinensis, 10 parts of Radix Bupleuri (processed with vinegar), 10 parts of Rhizoma Alismatis, 10 parts of Radix Glycyrrhizae, 10 parts of Herba Violaes, 10 parts of Cortex Moutans.Its preparation comprises that acceptable is fit to all dosage forms of using for oral administration clinically.
The raw medicinal material that the present invention chooses, all medicines are shared, have blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis, bactericidal antiphlogistic effect.Has good efficacy at urgent chronic pelvic inflammatory disease.Patient's 185 examples, effective percentage 100% are accepted in outpatient service for medical treatment; Determined curative effect of the present invention is treated with low costly, without any side effects, cure not to have recurrence.
The specific embodiment
The Chinese medicine preparation of treatment pelvic inflammatory disease of the present invention, raw medicinal material and the composition by weight thereof chosen are respectively: 50 parts of Herba Taraxaci, 20 parts of Fructus Forsythiaes, finish slack 12 parts, 12 parts of Flos Lonicerae, 20 parts of Herba Houttuyniae, 15 parts of Caulis Sargentodoxaes, 25 parts of Caulis Spatholobis, go into 10 parts of fragrant systems, 10 parts of Myrrha systems, 10 parts of Fructus Toosendans, 12 parts of Rhizoma Corydalis, 12 parts of Radix Gentianaes, fry 10 parts of mountain Gardenia, 10 parts of Semen Plantaginiss, 12 parts of Radix Angelicae Sinensis, 10 parts of Radix Bupleuri (processed with vinegar), 10 parts of Rhizoma Alismatis, 10 parts of Radix Glycyrrhizae, 10 parts of Herba Violaes, 10 parts of Cortex Moutans.Its preparation comprises that acceptable is fit to all dosage forms of using for oral administration clinically.
Claims (1)
1. Chinese medicine preparation for the treatment of pelvic inflammatory disease, it is characterized in that: raw medicinal material and the composition by weight thereof chosen are respectively: 50 parts of Herba Taraxaci, 20 parts of Fructus Forsythiaes, finish 12 parts of Xie, 12 parts of Flos Lonicerae, 20 parts of Herba Houttuyniae, 15 parts of Caulis Sargentodoxaes, 25 parts of Caulis Spatholobis, go into 10 parts of fragrant systems, 10 parts of Myrrha systems, 10 parts of Fructus Toosendans, 12 parts of Rhizoma Corydalis, 12 parts of Radix Gentianaes, fry 10 parts of Fructus Gardeniae, 10 parts of Semen Plantaginiss, 12 parts of Radix Angelicae Sinensis, 10 parts of Radix Bupleuri (processed with vinegar), 10 parts of Rhizoma Alismatis, 10 parts of Radix Glycyrrhizae, 10 parts of Herba Violaes, 10 parts of Cortex Moutans; Its preparation comprises that acceptable is fit to all dosage forms of using for oral administration clinically.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910211286A CN101810737A (en) | 2009-11-09 | 2009-11-09 | Chinese medicinal preparation for treating pelvic inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910211286A CN101810737A (en) | 2009-11-09 | 2009-11-09 | Chinese medicinal preparation for treating pelvic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101810737A true CN101810737A (en) | 2010-08-25 |
Family
ID=42618197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910211286A Pending CN101810737A (en) | 2009-11-09 | 2009-11-09 | Chinese medicinal preparation for treating pelvic inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101810737A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102512597A (en) * | 2011-12-22 | 2012-06-27 | 姜丽涛 | Traditional Chinese medicinal externally-used ointment for treating pelvic inflammatory masses |
| CN102973876A (en) * | 2013-01-01 | 2013-03-20 | 王瑞华 | Drug for treating pathological leukorrhagia |
| CN103393989A (en) * | 2013-07-24 | 2013-11-20 | 赵世明 | Traditional Chinese medicine composition for treating gynecologic inflammation |
| CN105250519A (en) * | 2015-10-19 | 2016-01-20 | 黄淮学院 | Traditional Chinese medicine composition for relieving sequelae of pelvic inflammatory disease and application of traditional Chinese medicine composition |
| CN106822329A (en) * | 2016-11-15 | 2017-06-13 | 劳冠阳 | Treatment acute pelvitis of pelvic cavity causes the medicine of pain in the back |
-
2009
- 2009-11-09 CN CN200910211286A patent/CN101810737A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102512597A (en) * | 2011-12-22 | 2012-06-27 | 姜丽涛 | Traditional Chinese medicinal externally-used ointment for treating pelvic inflammatory masses |
| CN102973876A (en) * | 2013-01-01 | 2013-03-20 | 王瑞华 | Drug for treating pathological leukorrhagia |
| CN103393989A (en) * | 2013-07-24 | 2013-11-20 | 赵世明 | Traditional Chinese medicine composition for treating gynecologic inflammation |
| CN103393989B (en) * | 2013-07-24 | 2015-06-10 | 夏君秀 | Traditional Chinese medicine composition for treating gynecologic inflammation |
| CN105250519A (en) * | 2015-10-19 | 2016-01-20 | 黄淮学院 | Traditional Chinese medicine composition for relieving sequelae of pelvic inflammatory disease and application of traditional Chinese medicine composition |
| CN105250519B (en) * | 2015-10-19 | 2019-09-03 | 黄淮学院 | A traditional Chinese medicine composition for alleviating sequelae of pelvic inflammatory disease and its application |
| CN106822329A (en) * | 2016-11-15 | 2017-06-13 | 劳冠阳 | Treatment acute pelvitis of pelvic cavity causes the medicine of pain in the back |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102861208B (en) | Antibacterial, anti-inflammation and antiviral traditional Chinese medicine compound | |
| CN101274093A (en) | Chinese medicine for curing fungal dermatopathy | |
| CN102973862B (en) | Chinese medicine preparation for treating skin itch | |
| CN104606582B (en) | For treating the Chinese medicine preparation of cold rheumatoid joint pain | |
| CN101810737A (en) | Chinese medicinal preparation for treating pelvic inflammation | |
| CN104771666A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN1698745B (en) | Externally applied anti-inflammation Chinese medicine composition | |
| CN103157058A (en) | Traditional Chinese water-bindered pill preparation for treating osteomyelitis | |
| CN102078524A (en) | Chinese traditional medicine composition for treating pharyngitis | |
| CN113769047A (en) | Eczema, allergy/allergy complex antimicrobial therapy | |
| CN101653540B (en) | Traditional Chinese medicine composition for treating pustule type psoriasis | |
| CN102988818A (en) | Traditional Chinese medicine formulation for treating arthralgia | |
| CN102038920A (en) | Pulse-invigorating capsule | |
| CN101623413A (en) | Chinese medicinal composition for treating women mastitis | |
| CN1173721C (en) | External-use trauma treating ointment | |
| CN100335116C (en) | Medicament for treating leprous psora | |
| CN103446555A (en) | Chinese medicinal composition for treating cholecystitis | |
| CN103479815A (en) | Traditional Chinese medicine for treating urinary tract infection | |
| CN101991696A (en) | Chinese material medical preparation for treating urticaria | |
| CN101991795A (en) | Traditional Chinese medicine preparation for treating pelvic inflammation | |
| CN102824456A (en) | Specific medicine for treating animal aftosa | |
| CN102018811A (en) | Chinese materia medica preparation for treating urticaria | |
| CN102038904A (en) | Chinese prescription for treating leucoderma | |
| CN105055580A (en) | Traditional Chinese medicine for treating cold | |
| CN102068559A (en) | Formula of traditional Chinese medicine for treating anal fissure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100825 |